What is the recommended initial test to assess bone density in a 73-year-old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Initial Test for Bone Density Assessment in a 73-Year-Old Female

Dual-energy X-ray absorptiometry (DXA) is the recommended initial test to assess bone density in a 73-year-old female. 1

Rationale for DXA as First-Line Test

  • DXA is the primary diagnostic modality recommended by the American College of Radiology (ACR) for screening women over 65 years of age for osteoporosis 1
  • DXA provides accurate bone mineral density (BMD) measurements that have been shown to predict fracture risk with high reliability 1, 2
  • DXA is considered the "gold standard" method for non-invasive diagnosis of osteoporosis with acceptable accuracy, good precision, and reproducibility 3, 4
  • The World Health Organization (WHO) has established diagnostic criteria for osteoporosis based on DXA measurements 3

Specific Anatomic Sites for DXA Measurement

  • Bone density measured at the femoral neck by DXA is the best predictor of hip fracture and comparable to forearm measurements for predicting fractures at other sites 1
  • Standard DXA assessment typically includes measurement of both:
    • Lumbar spine (L1-L4) 1
    • Proximal femur (total hip and femoral neck) 1, 5
  • Femoral neck BMD has shown the highest odds ratio for identifying subjects with vertebral fractures 5

Advantages of DXA Over Other Modalities

  • Lower radiation exposure compared to other imaging techniques like Quantitative CT (QCT) 2
  • Widespread availability and standardization 2
  • Established reference databases for comparison and calculation of T-scores 3
  • Better predictive ability for fracture risk than clinical risk factors alone 6

Interpretation of DXA Results

  • Results are reported as T-scores, representing the number of standard deviations from the mean BMD of a young healthy reference population 3
  • WHO diagnostic criteria based on T-scores:
    • Normal: T-score greater than -1.0
    • Osteopenia (low bone mass): T-score between -1.0 and -2.4
    • Osteoporosis: T-score equal to or less than -2.5 1

Special Considerations

  • Approximately 16% of lumbar spine scans may be unreadable due to degenerative changes, which are common in elderly patients 5
  • In patients with advanced degenerative changes in the spine, Quantitative CT (QCT) may be a useful alternative 1
  • Vertebral Fracture Assessment (VFA), which can be performed on some DXA machines, may provide additional fracture risk information 1
  • Potential artifacts that can affect DXA measurements include osteoarthritis, previous fractures, and jewelry 2

Follow-up Recommendations

  • Due to limitations in testing precision, a minimum of 2 years is typically needed to reliably measure changes in bone mineral density 1
  • Follow-up DXA scans are recommended to:
    • Assess the effectiveness of osteoporosis drug therapy
    • Monitor medical conditions associated with abnormal BMD 1

By following these evidence-based recommendations for bone density assessment in a 73-year-old female, clinicians can accurately identify osteoporosis, estimate fracture risk, and monitor response to treatment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dual-energy X-ray Absorptiometry.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2017

Research

DXA scanning in clinical practice.

QJM : monthly journal of the Association of Physicians, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.